Wyetts commit $50 million bequest—largest in Brigham history
The couple’s forward-thinking generosity will touch the lives of patients, staff, and scientists for generations to come.
Read more
All News & Stories
Showing 81 - 90 of 305 stories
Ladders to Health
Patients and experts share their science-backed steps for sustainable health
Truth, Lies, or Marketing?
How health misinformation circulates in the age of social media and how you can protect yourself and combat its spread.
Greater Expectations
Vaccines have helped double lifespans in many nations over the past 200 years. Learn how to counter misinformation around vaccines.
Finding True North
Improving tools and eliminating obstacles provides everyone with better paths to the right care.
Help Us Improve Brain Health
Support innovative work to transform brain disease prevention and treatment
SPORE Collaboration Plants the Seed for Cancer Drug Approval
This spring, in the latest example of success that has emerged from the SPORE, the Food and Drug Administration granted accelerated approval of the oral drug tovorafenib.
Stay connected.
Join our email list to get updates sent right to your inbox.
Form submitted successfully, thank you!
Stroke Patient Makes Full Recovery Thanks to the Brigham
Bonnie Slater-Demont shares her gratitude for making a full recovery. "Thank God for the Brigham."
Study Finds Ketamine Is at Least as Effective as ECT for Treating Major Depression
Major Depressive Disorder (MDD) is a leading cause of disability worldwide and is estimated to affect 21 million adults in the United States.
Parkinson’s Disease Therapies: Genomic Insights and Stem-Cell Innovations
Both genetic and environmental factors cause Parkinson’s disease. The overarching goal is to develop patient-tailored therapies to prevent or slow down the disease.
